These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11231046)

  • 1. Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
    Pintore M; Bernard P; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):21-30. PubMed ID: 11231046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular modeling and 3D QSAR study of a large series of indole inhibitors of human non-pancreatic secretory phospholipase A2.
    Bernard P; Pintore M; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):1-19. PubMed ID: 11231045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A(2).
    Mouchlis VD; Mavromoustakos TM; Kokotos G
    J Chem Inf Model; 2010 Sep; 50(9):1589-601. PubMed ID: 20795712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
    Schevitz RW; Bach NJ; Carlson DG; Chirgadze NY; Clawson DK; Dillard RD; Draheim SE; Hartley LW; Jones ND; Mihelich ED
    Nat Struct Biol; 1995 Jun; 2(6):458-65. PubMed ID: 7664108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.
    Lindahl M; Tagesson C
    Inflammation; 1997 Jun; 21(3):347-56. PubMed ID: 9246576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832.
    Binisti C; Mounier C; Touboul E; Heymans F; Bon C; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):171-87. PubMed ID: 9246606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidic mimetics as inhibitors of pancreatic phospholipase A2.
    Nicolaou A; Kokotos G; Constantinou V; York J; Gibbons WA
    Biochem Soc Trans; 1995 Nov; 23(4):614S. PubMed ID: 8654799
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbocyclic[g]indole inhibitors of human nonpancreatic s-PLA2.
    Sawyer JS; Beight DW; Smith EC; Snyder DW; Chastain MK; Tielking RL; Hartley LW; Carlson DG
    J Med Chem; 2005 Feb; 48(3):893-6. PubMed ID: 15689175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.
    Dileep KV; Remya C; Tintu I; Haridas M; Sadasivan C
    J Mol Model; 2013 Apr; 19(4):1811-7. PubMed ID: 23315198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.
    Draheim SE; Bach NJ; Dillard RD; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5159-75. PubMed ID: 8978844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors.
    Magolda RL; Galbraith W
    J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).
    Bridonneau P; Chang YF; O'Connell D; Gill SC; Snyder DW; Johnson L; Goodson T; Herron DK; Parma DH
    J Med Chem; 1998 Mar; 41(6):778-86. PubMed ID: 9526554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structures of human phospholipase A2 from pancreas and synovial fluid by model building.
    Christensen IT; Jørgensen FS; Svensson LA; Högberg T
    Drug Des Discov; 1993 Jun; 10(2):101-13. PubMed ID: 8399996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2.
    Dijkstra BW; Renetseder R; Kalk KH; Hol WG; Drenth J
    J Mol Biol; 1983 Jul; 168(1):163-79. PubMed ID: 6876174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex.
    Bennion C; Connolly S; Gensmantel NP; Hallam C; Jackson CG; Primrose WU; Roberts GC; Robinson DH; Slaich PK
    J Med Chem; 1992 Aug; 35(16):2939-51. PubMed ID: 1501221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
    Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
    Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition.
    Binisti C; Touboul E; Mounier C; Heymans F; Bon C; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jan; 15(2):125-44. PubMed ID: 9034960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.